medigraphic.com
Boletín Médico del Hospital Infantil de México

2009, Number 3

<< Back Next >>

Bol Med Hosp Infant Mex 2009; 66 (3)

Coexistence of C677T and A1298C mutations in the 5,10 methylenetetrahydrofolate reductase enzyme in pediatric patients with thrombosis

Parra-Ortega I, López-Martínez B, González-Ávila I, Rodríguez-Castillejos C, Jonguitud-Díaz V, Luna-Gaspar A, Sánchez-Huerta JL, Vilchis-Ordóñez A

Language: Spanish
References: 18
Page: 229-233
PDF size: 126.92 Kb.


ABSTRACT

Introduction. One of the thrombophilic conditions that has been widely studied is the C677T mutation in the gene encoding the 5,10 methylenetetrahydrofolate reductase (MTHFR) enzyme. The presence of mutation A1298C in the same gene is also considered as one factor that predisposes thrombosis. Methods. We report on 9 pediatric patients diagnosed with thrombophilia, 7 males and 2 females with ages ranging from 1 month to 13 years. Real-time polymerase chain reaction was performed along with the study of the C677T and A1298C mutations in the MTHFR enzyme, G1691A mutation (Leiden) and factor V, prothrombin mutation G20210A. Conventional methods were used for activated protein C (APC) resistance and protein C and S coagulation, as well as antithrombin (AT). Results. All patients had coexisting mutations C677T and A1298C in MTHFR. Only 1 patient was homozygous for C677T and heterozygous for A1298C. The other 8 patients presented heterozygous mutations and in the 9 patients the presence of mutations of G1691A factor V (Leiden) and G20210A prothrombin was not demonstrated, as well as alterations in APC, AT and proteins C and S. Conclusions.Coexistence of the C677T and A1298C mutations should be considered for investigation in all patients presenting thrombophilia.


REFERENCES

  1. De Veber G, Andrew M, Adams C. Cerebral sinovenous thrombosis in children. N Engl J Med. 2001; 345: 417-23.

  2. Tuckuviene R, Johnsen SP, Helgestad J, Ingerslev J, Kristensen SR. Venous thromboembolism in children. Ugeskr Laeger. 2008; 170: 3424-9.

  3. Schmidt B, Andrew M. Neonatal thrombosis: Report of a prospective Canadian and international registry. Pediatrics. 1995; 96: 939-43.

  4. Ruiz-Argüelles GJ. Trombofilia. En: Ruiz-Argüelles GJ, editor. Fundamentos de hematología. 3ª ed. México: Editorial Médica Panamericana; 2003. p. 424-36.

  5. Ruiz-Argüelles GJ, González-Estrada S, Garcés-Eisele J, Ruiz-Argüelles A. Primary thrombophilia in México: A prospective study. Am J Hematol. 1999; 60: 1-5.

  6. Ruiz-Argüelles GJ, Garcés-Eisele J, Reyes-Núñez V, Ramírez-Cisneros F. Primary thrombophilia in México. II: Factor V G1691A (Leiden), prothrombin G20210A and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos. Am J Hematol. 2001; 66: 28-31.

  7. Ruiz-Argüelles GJ, López-Martínez B, Cruz-Cruz D, Reyes-Aulis MB. Primary thrombophilia in México. III: A prospective study of the sticky platelet syndrome. Clin Appl Thromb Hemost. 2002; 8: 273-7.

  8. Ruiz-Argüelles GJ, Poblete-Naredo I, Reyes-Nuñez V, Garcés-Eisele J, López-Martínez B, Gómez-Rangel D. Primary thrombophilia in México. IV: Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican mestizos. Rev Invest Clin Mex. 2004; 56: 600-4.

  9. Ruiz-Argüelles GJ, López-Martínez B, Valdés-Tapia P, Gómez-Rangel JD, Reyes-Nuñez V, Garcés-Eisele J. Primary thrombophilia in México. V. A comprehensive prospective study indicates that most cases are multifactorial. Am J Hematol. 2005; 78: 21-6.

  10. Ruiz-Argüelles GJ, González-Carrillo ML, Estrada-Gómez R, Valdés-Tapia P, Parra-Ortega I, Porras-Juárez A. Primary thrombophilia in México. VI. Falta de asociación estadística entre las condiciones trombofílicas heredadas. Gac Med Mex. 2007; 4: 317-22.

  11. Sibani S, Christensen B, O’Ferrell E. Characterization of six novel mutations in the methylenetetrahydrofolate reductase (MTHFR) gene in patients with homocystinuria. Hum Mutat. 2000; 15: 280-7.

  12. Van der Put NJM, Gabreels F, Stevens EMB, Smeitink JAM, Trijbels FJM, Eskes TKAB, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: An additional risk factor for neural tube defects? Am J Hum Genet. 1998; 62: 1044-51.

  13. Malinow MR, Nieto FJ, Kruger WD. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol. 1997; 17: 1157-62.

  14. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in MTHFR associated with decreased enzyme activity. Mol Genet Metab. 1998; 64: 169-72.

  15. Friedman G, Goldschmidt N, Friedlander Y. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: Association with plasma total homocysteine and folate concentrations. J Nutr. 1999; 129: 1656-61.

  16. Parra-Ortega I, Estrada-Gómez RA, Guzmán-García MO. La mutación 677 C ® T en la 5,10 metilentetrahidrofolato reductasa y el aumento de homocisteína en pacientes mexicanos. Med Intern Mex. 2007; 23: 15-8.

  17. Reyes-Engel A, Muñoz E, Gaitán MJ. Implications on human fertility of the 677C ® T and 1298A ® C polymorphisms of the MTHFR gene: Consequences of a possible genetic selection. Mol Hum Reprod. 2002; 8: 952-7.

  18. Ozyurek E, Balta G, Degerliyurt A, Parlak H, Aysun S, Gürsey A. Significance of factor V, prothrombin, MTHFR, and PAI-1 genotypes in childhood cerebral thrombosis. Clin Appl Thromb Hemost. 2007; 13: 154-60.




2020     |     www.medigraphic.com